Device Oncology

Varian Cryocare Touch System

Payments companies reported to CMS as associated with Varian Cryocare Touch System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$59Kassociated payments (2023-2025)
394clinicians with associated payments
1company reporting

By year

2023 $19K
2024 $17K
2025 $23K

Payments reported as associated with Varian Cryocare Touch System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Vascular & Interventional Radiology $28K
Diagnostic Radiology $24K
Urology $2,050
Family $694
Physician Assistant $472
Hospice and Palliative Medicine (Internal Medicine) $426

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Varian Cryocare Touch System

These are the largest totals companies reported as associated with Varian Cryocare Touch System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Florian Fintelmann Boston, MA Diagnostic Radiology $13,704.05
Govindarajan Narayanan Miami, FL Vascular & Interventional Radiology $3,912.55
Brandon Key Milwaukee, WI Vascular & Interventional Radiology $2,524.90
Al Barqawi Aurora, CO Urology $1,298.04
Jun Man Kim Atlanta, GA Vascular & Interventional Radiology $877.75
Junjian Huang Birmingham, AL Vascular & Interventional Radiology $834.11
Jeanne Stryker Solana Beach, CA Vascular & Interventional Radiology $656.30
Henry Krebs Newnan, GA Diagnostic Radiology $613.55
James Thomasson Jackson, MS Vascular & Interventional Radiology $608.40
Kathryn Parvin Jackson, MS Vascular & Interventional Radiology $559.61

Prescribed Varian Cryocare Touch System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.